2017-08-15T09:32:26-05:00 2016-12-31 221732349 WISS & COMPANY LLP 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 990PF 2016-01-01 306068334 THE LEANDRO P RIZZUTO FOUNDATION C/O PAUL WEISS RIFKIND WHARTON & GARR LEAN 2123733026 1285 AVENUE OF THE AMERICAS NEW YORK NY 10019 CARL L REISNER TRUSTEE 2123733026 2017-08-14 1 MICHAEL LAMOTTA P00041212 9739949400 50.202.92.84 2017-08-14 16:18:38 ED P C43DC492DCFCAD84A7AE1B0A90AA2049B5DC8FED 95E3ED7670F1DF5B3CF53D6854EC6A071594F466 2016 2021-01-29 14:40:06Z X 11826439 X 14433968 534 534 137 137 0 14434639 671 0 0 0 115820 0 115820 28000 11200 16800 113772 0 113772 26552 0 26552 18745 0 11988 302889 11200 284932 9813838 5931639 10116727 11200 6216571 4317912 0 385312 6817440 6817440 3263448 0 5000000 5000000 11171 2172 0 8999 8999 3648760 11826439 11826439 31379 3882199 53811 0 53811 3913578 X 3265063 4295675 329886 3617186 3594949 7912861 3648760 11826439 3594949 4317912 0 7912861 0 7912861 0 3735457 5880527 0.635225 1540305 337507 4.563772 100200 198698 0.504283 650750 166601 3.906039 1749974 662893 2.639904 12.249223 2.449845 9514811 23309812 0 23309812 6216571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 AL AR AK CA CO CT DC FL GA HI IL KS KY ME MD MA MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI 1 0 0 0 0 1 HTTP://ALSFINDINGACURE.ORG TRUSTEE 2123733026 1285 AVENUE OF THE AMERICAS NEW YORK NY 10019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 CARL L REISNER C/O PAUL WEISSRIFKIND WHARTON GARR 1285 AVENUE OF THE AMERICAS NEW YORK NY 10019 TRUSTEE 2.00 0 0 0 NONE 0 NONE 0 0 407208 4252499 5000000 9659707 0 0 9659707 144896 9514811 475741 475741 0 475741 0 475741 0 475741 6216571 0 6216571 0 6216571 475741 0 0 1486881 642420 90265 1436108 3453668 7109342 6216571 0 0 2000 475741 5738830 0 0 12850172 0 0 0 0 0 2000 1484881 11363291 642420 90265 1436108 3453668 5740830 X ALS THERAPY DEVELOPMENT INSTITUTE 300 TECH SQUARE CAMBRIDGE MA 02139 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 250000 AMYLYX PHARMACEUTICALS INC NGIN WORKPLACE 210 BROADWAY 201 CAMBRIDGE MA 02139 NONE NC IND-ENABLEMENT GRANT 150000 BROWN UNIVERSITY BOX 1911 164 ANGELL STREET PROVIDENCE RI 02912 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 790312 CEDARS SINAI MEDICAL CENTER 6500 WILSHIRE BLVD SUITE 1150 LOS ANGELES CA 90048 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 243864 DIGNITY HEALTH - ST JOSEPH'S ATTN MISC A/R CASH FILE 57431 LOS ANGELES CA 900748781 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 135429 EMORY ALS CENTER 101 WOODRUFF CIRCLE SUITE 6000 ATLANTA GA 30322 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 124862 GE GLOBAL RESEARCH 1 RESEARCH CIRCLE NISKAYUNA NY 12309 NONE NC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 43203 GLADSTONE INSTITUTE 1650 OWENS STREET SAN FRANCISCO CA 941582216 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 127779 MASSACHUSETTS GENERAL HOSPITAL BANK OF AMERICA PO BOX 414876 BOSTON MA 02114 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 1956359 METHODIST HOSPITAL RESEARCH INSTITUTE 6670 BERTNER R2-216 HOUSTON TX 77030 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 80775 THE OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 124862 UNIVERSITY OF CALIFORNIA IRVINE BIOLOGICAL SCIENCES III 3214 MAIL CODE 4545 IRVINE CA 92697 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 163178 UNIVERSITY OF MASS MEDICAL SCHOOL 55 LAKE AVE NORTH WORCESTER MA 01655 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 78584 WASHINGTON UNIVERSITY 115 BIOTECH BLDG BOX 8111 660 S EUCLID ST LOUIS MO 63110 NONE PC RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS. 162432 WEILL CORNELL MEDICAL COLLEGE 1300 YORK AVENUE BOX 314 NEW YORK NY 10065 NONE PC TRANSLATION OF BASIC SCIENCE DISCOVERY TO TREATING PANCREATIC DISEASE 1500000 5931639 WEILL CORNELL MEDICAL COLLEGE 1300 YORK AVENUE BOX 314 NEW YORK NY 10065 NONE PC TARGETING PANCREATIC CANCER STEM CELLS AND TUMORS OF DEFINED GENETIC BACKGROUND 4000000 4000000 14 534 14 137 0 671 0 671 0 0 0 0 0 0 0 0 0 0 X X 1 LEANDRO P RIZZUTO 75 RAPID CREEK ROAD SHERIDAN WY 82801 13815679 X 2 NFL FOUNDATION ATTN ANNA ISAACSON 345 PARK AVE NEW YORK NY 10065 500000 X 3 THOMAS AND JULIE GENTILE 178 HILLSPOINT ROAD WESTPORT CT 06880 10000 X 4 DENIS RIZZUTO 229 BYRAM SHORE ROAD GREENWICH CT 06830 100000 X ACCOUNTING FEES 28000 11200 16800 WEBSITE COST 2016-06-07 11171 36.000000000000 2172 0 2172 PURSUANT TO IRC SECTION 4942(G)(3) AND REG. 53.4942(A)-3, THE FOUNDATION HEREBY ELECTS TO TREAT CURRENT YEAR QUALIFYING DISTRIBUTIONS AS BEING MADE OUT OF CORPUS.TAX YEAR: 12/31/2016AMOUNT: $2,000 GENERAL ELECTRIC GLOBAL RESEARCH PNC BANK C/O GENERAL ELECTRIC CO LOCKBOX 645044 PITTSBURGH PA 15219 2014-10-01 621431 RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.PAYMENTS ARE MADE AT THE BEGINNING OF EACH MILESTONE.ANNUALLY, GE AGREES TO PROVIDE THE CHARITIES WITH FULL AND COMPLETE FINANCIAL REPORTS AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE STATEMENT OF WORK. TOTAL GRANT AMOUNT: $621,431 MRI BRAIN: $268,644PET BRAIN: $110,604MULTIOMYX TO ALS IPSC: $187,440NOVEL IMPAGING ANIMAL: $54,743 43203 NONE ONGOING 2016-01-01 AMYLYX PHARMACEUTICALS INC NGIN WORKPLACE 210 BROADWAY 201 CAMBRIDGE MA 02139 2016-06-06 750000 IND-ENABLING STUDIES TO BRING THERAPEUTIC DIRECTLY TO PATIENTS 150000 NONE EVERY THREE MONTHS FROM 6/6/2016 OR UPON REQUEST 2016-06-06 MISSION RELATED INVESTMENT 990-PF, PART II, LINE 13 THE FOUNDATION ENTERED INTO A STOCK PURCHASE AGREEMENT WITH A FOR PROFIT ENTITY, EMULATE, INC., PURCHASING 2,000,000 OUT OF 18,000,000 SHARES OF SERIES B PREFERRED STOCK. THE COMPANY CREATED A TECHNOLOGY THAT EMULATES HUMAN BIOLOGY TO AID IN THE UNDERSTANDING OF HOW DISEASES, MEDICINES, CHEMICALS AND FOODS AFFECT HUMAN HEALTH. THE APPLICATION OF SUCH TECHNOLOGY IS EXPECTED TO AID IN THE RESEARCH AND CURE OF DISEASE (INCLUDING ALS), WHICH IS IN FURTHERANCE OF THE FOUNDATION'S EXEMPT PURPOSES. RECLASSIFICATON OF BEGINNING NET ASSETS FORM 990-PF, PART II, LINE 24 AND 25 SUBSEQUENT TO THE FILING OF THE 2015 "RETURN OF PRIVATE FOUNDATION" (990PF), THE ORGANIZATION DECIDED TO REPORT NET ASSETS UNDER SFAS 117. TOTAL BEGINNING NET ASSETS OF $3,594,949 REMAIN UNCHANGED, HOWEVER, BEGINNING NET ASSETS OF $3,265,063 WERE RECLASSIFIED AS UNRESTRICED NET ASSETS AND $329,886 AS TEMPORARILY RESTRICTED NET ASSETS. MISSION RELATED INVESTMENT AT COST 5000000 5000000 WEBSITE COST 11171 2172 8999 8999 LEGAL FEES 115820 0 115820 BUSINESS REGISTRATION FEES 11828 0 11828 BANK FEES 4510 0 0 PAYPAL FEES 160 0 160 OFFICE EXPENSES 23 0 0 BUSINESS EXPENSES 52 0 0 AMORTIZATION 2172 0 0 OTHER LIABILITIES 53811 0 CONSULTING FEES 113772 0 113772